Remus Pharmaceuticals Limited — Board Meeting, 27-02-2025: Outcome of Board Meeting

The Board of Directors of Remus Pharmaceuticals has announced a board meeting outcome focusing on key decisions. The Board approved the voluntary adoption of Indian Accounting Standards (Ind AS), effective April 1, 2024, to enhance transparency and align with international practices. They also withdrew a prior resolution for incorporating a wholly owned subsidiary in the USA following the acquisition of Espee Global Holdings LLC. Additionally, amendments were made to the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information to comply with regulatory requirements.